CbI, a negative regulator of immune signaling, ha recently been shown to ac
t as a ubiquitin-protein Further, two new papers describing Cbl-b-deficient
mice suggest that CbI-b sets the threshold of signaling in T and B cells a
nd prevents the development of autoimmunity.